Population based study of use of anticoagulants among patients with atrial fibrillation in the community

M. Sudlow,H. Rodgers,Anne Kenny Rose,R. Thomson
DOI: https://doi.org/10.1136/bmj.314.7093.1529
1997-05-24
British Medical Journal
Abstract:Several randomised controlled trials have shown that warfarin treatment for patients with atrial fibrillation substantially reduces their risk of stroke.1 Studies have found low treatment rates among patients with atrial fibrillation in hospital2 and in primary care,3 but these have been limited by their reliance on identifying patients with atrial fibrillation from coding of records and prescription of antiarrhythmic drugs. We report the use of warfarin among patients with atrial fibrillation in a community survey. Concern has been expressed about the high rates of exclusion of subjects from randomised trials of warfarin treatment. It has been suggested that the use of similar exclusions in clinical practice would greatly reduce the number of patients eligible for treatment,4 which might explain the low treatment rates. We therefore applied exclusion criteria similar to one of these trials …
What problem does this paper attempt to address?